Thursday, Aug 06, 2020 | Last Update : 12:46 AM IST

133rd Day Of Lockdown

Maharashtra45795629935616142 Tamil Nadu2682852087844349 Andhra Pradesh176333956251604 Karnataka145830692722704 Delhi1391561252264033 Uttar Pradesh100310572711817 West Bengal80984568841785 Telangana6894649675563 Gujarat65704485612529 Bihar6203140760349 Assam4816233429115 Rajasthan4667932832732 Haryana3779631226448 Odisha3768124483258 Madhya Pradesh3508225414912 Kerala279561629988 Jammu and Kashmir2239614856417 Punjab1901512491462 Jharkhand140705199129 Chhatisgarh10109761369 Uttarakhand8008484795 Goa7075511460 Tripura5520367528 Puducherry4147253758 Manipur301818147 Himachal Pradesh2879171013 Nagaland24056594 Arunachal Pradesh179011053 Chandigarh120671520 Meghalaya9173305 Sikkim7832971 Mizoram5022820
  Science   21 Jun 2020  Now US also stops hydroxychloroquine trial on COVID-19 patients

Now US also stops hydroxychloroquine trial on COVID-19 patients

REUTERS
Published : Jun 21, 2020, 11:17 am IST
Updated : Jun 21, 2020, 11:17 am IST

Researchers in US’s NIH find the drug, which is widely used in India as well, did not provide any benefit to coronavirus patients

 A chemist displays hydroxychloroquine tablets in New Delhi, India.(AP)
  A chemist displays hydroxychloroquine tablets in New Delhi, India.(AP)

The U.S. National Institutes of Health said on Saturday it has halted a clinical trial to evaluate the safety and effectiveness of the malaria drug hydroxychloroquine for the treatment of hospitalized COVID-19 patients.

The study found that hydroxychloroquine, which President Donald Trump has frequently touted a possible treatment, did not provide any benefit to the patients, even though it did no harm, NIH said in a statement.

 

Earlier this week, the World Health Organization said testing of hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after new data and studies showed no benefit.

The U.S. Food and Drug Administration revoked its emergency use authorization for hydroxychloroquine to treat COVID-19 on Monday.

Trump had promoted the drug as a potential treatment, saying in March it could turn out to be “one of the biggest game changers in the history of medicine” when used in combination with the antibiotic azithromycin.

Last month, in a surprise announcement, Trump said he was taking a course of hydroxychloroquine as a preventative after two White House aides tested positive for the novel coronavirus that causes COVID-19.

 

NIH announced its trial of hydroxychloroquine, which is used to treat malaria and rheumatoid conditions such as arthritis, in April.

Tags: hydroxychloroquine, coronavirus, covid-19, trial, donald trump, malaria medicine